Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples